Moving the Needle on COVID-19 Paediatric Vaccines: An Examination of Recent Legal Trends
- Shibley Righton
- Jan 31, 2022
- 1 min read
Moving the Needle on COVID-19 Paediatric Vaccines: An Examination of Recent Legal Trends
Posted by: Ava Naraghi , January 31, 2022
On May 18, 2021, Health Canada approved the use of the Pfizer-BioNTech COVID-19 vaccine for children 12 years of age and older. In the months following the announcement, courts across the country have begun ruling on a new range of disputes between parents who disagree about whether their child should receive the vaccine.
